![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1761729
¼¼°èÀÇ ¾Ë·¹¸£±â Áø´Ü ¹× Ä¡·á ½ÃÀåGlobal Markets for Allergy Diagnostics and Treatments |
¼¼°è ¾Ë·¹¸£±â Áø´Ü ¹× Ä¡·á ½ÃÀå ±Ô¸ð´Â 2025³â 678¾ï ´Þ·¯¿¡¼ 2025³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 7.3%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â ¸»¿¡´Â 964¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹Ì ½ÃÀåÀº 2025³â 397¾ï ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ µ¿¾È CAGR 7.4%·Î ¼ºÀåÇÏ¿© 2030³â ¸»¿¡´Â 567¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº 2025³â 86¾ï ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ µ¿¾È CAGR 8.6%·Î ¼ºÀåÇÏ¿© 2030³â ¸»¿¡´Â 129¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ¾Ë·¹¸£±â Áø´Ü ¹× Ä¡·á ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.
The North American market for allergy diagnostics and treatment is projected to grow from $39.7 billion in 2025 to $56.7 billion by the end of 2030, at a CAGR of 7.4% from 2025 through 2030.
The Asia-Pacific market for allergy diagnostics and treatment is projected to grow from $8.6 billion in 2025 to $12.9 billion by the end of 2030, at a CAGR of 8.6% from 2025 through 2030.
This report will provide detailed information on allergy diagnostics and treatments. It analyzes the market trends, with the base year for the study being 2024. It provides estimates for 2025, and forecasts for 2025 through 2030, including the compound annual growth rate (CAGR) for the forecast period. It also analyzes regional markets. This report will highlight allergy diagnostics, current and future market potential of treatments, and a detailed competitive environment analysis. The report will cover regulatory scenarios, drivers, restraints, and opportunities. Also included will be market shares for key players.
The market is segmented into two major categories: diagnostics and treatments. Diagnostics include skin testing (prick, patch, intradermal) and blood testing (antibody). Treatments include antihistamines, sympathomimetics, decongestants and combinations, corticosteroids, leukotrienes, mast cell stabilizers, immunotherapy, and others. Immunotherapy is further segmented into subcutaneous administration, sublingual liquid solutions, and sublingual tablets. The treatments market is segmented into food, drug, inhaled, and others based on allergen type. Drug types are market segmented into prescription drug and over-the-counter (OTC).
The allergy diagnostics and treatment market has been segmented into North America, Europe, the Asia-Pacific, the Middle East and Africa (MEA), and South America. The detailed regional analysis will cover major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided with 2024 as the base year.